InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Benatti Luca, Director. Officer active across 1 companies, notably Intercept Pharmaceuticals, INC.. Aggregated, 3 disclosures have been published. The latest transaction was filed on 25 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
07,737 shares0
Common Stock
SEC:0001104659-22-065918:0·
07,029 shares0
Common Stock
SEC:0001104659-21-075215·
07,029 shares0
Common Stock
SEC:0001104659-21-075215:0·
3 of 3 declarations
About Benatti Luca
Luca Benatti is a Director at INTERCEPT PHARMACEUTICALS, INC. In this role, he participates in the governance and strategy of the company. INTERCEPT PHARMACEUTICALS, INC. is a biopharmaceutical company specializing in developing treatments for liver diseases. Luca Benatti brings his expertise in health to help guide strategic decisions.
